Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Bronchiolitis.

Smyth RL, Openshaw PJ.

Lancet. 2006 Jul 22;368(9532):312-22. Review.

PMID:
16860701
2.

Respiratory syncytial virus bronchiolitis.

Leung AK, Kellner JD, Davies HD.

J Natl Med Assoc. 2005 Dec;97(12):1708-13. Review.

3.

Prevention of respiratory syncytial virus infection with palivizumab.

Thomas M, Bedford-Russell A, Sharland M.

Monaldi Arch Chest Dis. 2000 Aug;55(4):333-8. Review.

PMID:
11057088
4.

Preventing RSV bronchiolitis in vulnerable infants: the role of palivizumab.

Fitzgerald DA.

Paediatr Respir Rev. 2009 Sep;10(3):143-7. doi: 10.1016/j.prrv.2009.06.002. Epub 2009 Jul 15. Review.

PMID:
19651385
5.

Palivizumab: an overview.

Russell AB.

Hosp Med. 1999 Dec;60(12):873-7. Review.

PMID:
10707171
6.

Respiratory syncytial virus disease: update on treatment and prevention.

Krilov LR.

Expert Rev Anti Infect Ther. 2011 Jan;9(1):27-32. doi: 10.1586/eri.10.140. Review.

PMID:
21171875
7.

Bronchiolitis: from empiricism to scientific evidence.

Carraro S, Zanconato S, Baraldi E.

Minerva Pediatr. 2009 Apr;61(2):217-25. Review.

PMID:
19322125
8.

Respiratory syncytial virus: how, why and what to do.

Rodriguez R, Ramilo O.

J Infect. 2014 Jan;68 Suppl 1:S115-8. doi: 10.1016/j.jinf.2013.09.021. Epub 2013 Oct 27. Review.

PMID:
24171820
9.

Management of respiratory syncytial virus infection.

Kimpen JL.

Curr Opin Infect Dis. 2001 Jun;14(3):323-8. Review.

PMID:
11964851
10.

Bronchiolitis.

Worrall G.

Can Fam Physician. 2008 May;54(5):742-3. Review. No abstract available.

11.

Palivizumab prophylaxis of respiratory syncytial virus infection in high-risk infants.

Vogel AM, Lennon DR, Broadbent R, Byrnes CA, Grimwood K, Mildenhall L, Richardson V, Rowley S.

J Paediatr Child Health. 2002 Dec;38(6):550-4. Review.

PMID:
12410864
12.

Inter-society consensus document on treatment and prevention of bronchiolitis in newborns and infants.

Baraldi E, Lanari M, Manzoni P, Rossi GA, Vandini S, Rimini A, Romagnoli C, Colonna P, Biondi A, Biban P, Chiamenti G, Bernardini R, Picca M, Cappa M, Magazzù G, Catassi C, Urbino AF, Memo L, Donzelli G, Minetti C, Paravati F, Di Mauro G, Festini F, Esposito S, Corsello G.

Ital J Pediatr. 2014 Oct 24;40:65. doi: 10.1186/1824-7288-40-65.

13.

Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction.

Panitch HB.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S83-7; discussion S87-8. Review.

PMID:
12671457
14.

Immunoprophylaxis against respiratory syncytial virus (RSV) with palivizumab in children: a systematic review and economic evaluation.

Wang D, Cummins C, Bayliss S, Sandercock J, Burls A.

Health Technol Assess. 2008 Dec;12(36):iii, ix-x, 1-86. Review.

15.

Palivizumab for preterm infants. Is it worth it?

Embleton ND, Harkensee C, Mckean MC.

Arch Dis Child Fetal Neonatal Ed. 2005 Jul;90(4):F286-9. Review.

16.

Bronchiolitis in infants.

Panitch HB.

Curr Opin Pediatr. 2001 Jun;13(3):256-60. Review.

PMID:
11389361
17.

Respiratory syncytial virus bronchiolitis.

Jeng MJ, Lemen RJ.

Am Fam Physician. 1997 Mar;55(4):1139-46, 1149-50. Review.

PMID:
9092277
18.

Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease.

Feltes TF, Sondheimer HM.

Expert Opin Biol Ther. 2007 Sep;7(9):1471-80. Review.

PMID:
17727335
19.

Relationship between respiratory syncytial virus bronchiolitis and future obstructive airway diseases.

Wennergren G, Kristjánsson S.

Eur Respir J. 2001 Dec;18(6):1044-58. Review.

20.

Acute bronchiolitis.

Teshome G, Gattu R, Brown R.

Pediatr Clin North Am. 2013 Oct;60(5):1019-34. doi: 10.1016/j.pcl.2013.06.005. Epub 2013 Jul 24. Review.

PMID:
24093893
Items per page

Supplemental Content

Write to the Help Desk